HUT49494A - Process for producing active component of pharmaceutical compositions - Google Patents
Process for producing active component of pharmaceutical compositionsInfo
- Publication number
- HUT49494A HUT49494A HU884518A HU451888A HUT49494A HU T49494 A HUT49494 A HU T49494A HU 884518 A HU884518 A HU 884518A HU 451888 A HU451888 A HU 451888A HU T49494 A HUT49494 A HU T49494A
- Authority
- HU
- Hungary
- Prior art keywords
- pharmaceutical compositions
- active component
- producing active
- producing
- component
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3730909 | 1987-09-15 | ||
| DE3802355 | 1988-01-27 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUT49494A true HUT49494A (en) | 1989-10-30 |
| HU205010B HU205010B (en) | 1992-03-30 |
Family
ID=25859774
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU884518A HU205010B (en) | 1987-09-15 | 1988-09-01 | Process for producing pharmaceutical compositions comprising compounds soluble up to 1 per cent and having medical activity |
Country Status (24)
| Country | Link |
|---|---|
| JP (1) | JP3090666B2 (hu) |
| KR (1) | KR0131084B1 (hu) |
| AT (1) | AT395819B (hu) |
| AU (1) | AU628787B2 (hu) |
| BE (1) | BE1001204A5 (hu) |
| CA (1) | CA1338775C (hu) |
| CH (1) | CH683672A5 (hu) |
| DK (1) | DK175132B1 (hu) |
| ES (1) | ES2012118A6 (hu) |
| FI (1) | FI94837C (hu) |
| FR (1) | FR2620336B1 (hu) |
| GB (1) | GB2209671B (hu) |
| GR (1) | GR1002243B (hu) |
| HU (1) | HU205010B (hu) |
| IE (1) | IE61195B1 (hu) |
| IL (1) | IL87746A (hu) |
| IT (1) | IT1224886B (hu) |
| LU (1) | LU87335A1 (hu) |
| MY (1) | MY103769A (hu) |
| NL (1) | NL195094C (hu) |
| NO (1) | NO179434C (hu) |
| NZ (1) | NZ226163A (hu) |
| PT (1) | PT88492B (hu) |
| SE (1) | SE503279C2 (hu) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2222770B (en) * | 1988-09-16 | 1992-07-29 | Sandoz Ltd | Pharmaceutical compositions containing cyclosporins |
| US6007840A (en) * | 1988-09-16 | 1999-12-28 | Novartis Ag | Pharmaceutical compositions comprising cyclosporins |
| GR1000466B (el) * | 1989-01-28 | 1992-07-30 | Sandoz Ag | Μεθοδος παρασκευης νεων φαρμακευτικων μορφων κυκλοσπορινης. |
| CH679277A5 (hu) * | 1989-02-09 | 1992-01-31 | Sandoz Ag | |
| GB8916901D0 (en) | 1989-07-24 | 1989-09-06 | Sandoz Ltd | Improvements in or relating to organic compounds |
| US6262022B1 (en) | 1992-06-25 | 2001-07-17 | Novartis Ag | Pharmaceutical compositions containing cyclosporin as the active agent |
| SG45449A1 (en) | 1992-05-13 | 1998-01-16 | Sandoz Ltd | Ophthalmic compositions |
| ES2168271T3 (es) | 1992-09-25 | 2002-06-16 | Novartis Ag | Composiciones farmaceuticas que contienen ciclosporinas. |
| DE69426408T2 (de) | 1993-09-28 | 2001-07-12 | Scherer Gmbh R P | Herstellung von Weichgelatinekapseln |
| PT789580E (pt) | 1994-11-03 | 2002-09-30 | Novartis Ag | Formulacoes de ciclosporina para administracao oral com composicao simples e alta biodisponibilidade e processo para a sua producao |
| US5962019A (en) * | 1995-08-25 | 1999-10-05 | Sangstat Medical Corporation | Oral cyclosporin formulations |
| US5766629A (en) * | 1995-08-25 | 1998-06-16 | Sangstat Medical Corporation | Oral cyclosporin formulations |
| US5827822A (en) * | 1996-03-25 | 1998-10-27 | Sangstat Medical Corporation | Cyclosporin a formulations as nanoparticles |
| US5834017A (en) * | 1995-08-25 | 1998-11-10 | Sangstat Medical Corporation | Oral cyclopsporin formulations |
| DE19549852B4 (de) | 1995-11-29 | 2009-06-04 | Novartis Ag | Cyclosporin enthaltende Präparate |
| TW414696B (en) * | 1996-07-01 | 2000-12-11 | Mitsubishi Kagaku Foods Kk | Anti-bacteria agent |
| CZ295207B6 (cs) | 1997-01-30 | 2005-06-15 | Novartis Ag | Tvrdá želatinová tobolka obsahující cyklosporin A |
| GB2326337A (en) * | 1997-06-20 | 1998-12-23 | Phares Pharma Holland | Homogeneous lipid compositions for drug delivery |
| US7732404B2 (en) | 1999-12-30 | 2010-06-08 | Dexcel Ltd | Pro-nanodispersion for the delivery of cyclosporin |
| WO2005037252A1 (en) * | 2003-10-14 | 2005-04-28 | Wockhardt Limited | Sterile gelling agents |
| JP5422871B2 (ja) * | 2006-10-24 | 2014-02-19 | 不二製油株式会社 | イソフラボン類組成物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE624258A (hu) * | 1961-10-31 | |||
| GB1134878A (en) * | 1966-05-12 | 1968-11-27 | Suga Kazuo | Improvements in and relating to oryzanol solutions and compositions |
| FR5986M (hu) * | 1966-11-22 | 1968-06-21 | ||
| BE787842A (fr) * | 1971-08-25 | 1972-12-18 | Sumito Chemical Cy Ltd | Procede de preparation d'une suspension aqueuse de cristaux stables du type non beta d'esters d'acides gras superieurs du chloramphenicol |
| JPS53107408A (en) * | 1977-02-28 | 1978-09-19 | Yamanouchi Pharmaceut Co Ltd | Micellar preparation for rectal infusion |
| SE445174B (sv) * | 1978-03-07 | 1986-06-09 | Sandoz Ag | Farmaceutisk komposition innehallande en cyklosporin och en berarsubstans |
| JPS57128634A (en) * | 1981-02-03 | 1982-08-10 | Eisai Co Ltd | Elastase-containing compound increasing absorption |
| EP0179583A1 (en) * | 1984-10-04 | 1986-04-30 | Merck & Co. Inc. | A system for enhancing the water dissolution rate and solubility of poorly soluble drugs |
| JPS61280435A (ja) * | 1985-04-04 | 1986-12-11 | Kanji Takada | サイクロスポリン類のリンパ指向性製剤 |
-
1988
- 1988-09-01 HU HU884518A patent/HU205010B/hu unknown
- 1988-09-12 CH CH3398/88A patent/CH683672A5/de not_active IP Right Cessation
- 1988-09-12 FR FR888811953A patent/FR2620336B1/fr not_active Expired - Lifetime
- 1988-09-12 BE BE8801044A patent/BE1001204A5/fr not_active IP Right Cessation
- 1988-09-12 LU LU87335A patent/LU87335A1/xx unknown
- 1988-09-13 IE IE277288A patent/IE61195B1/en not_active IP Right Cessation
- 1988-09-13 GB GB8821443A patent/GB2209671B/en not_active Expired - Lifetime
- 1988-09-13 PT PT88492A patent/PT88492B/pt not_active IP Right Cessation
- 1988-09-13 NO NO884052A patent/NO179434C/no not_active IP Right Cessation
- 1988-09-13 AU AU22172/88A patent/AU628787B2/en not_active Expired
- 1988-09-13 SE SE8803221A patent/SE503279C2/sv not_active IP Right Cessation
- 1988-09-13 CA CA000577214A patent/CA1338775C/en not_active Expired - Lifetime
- 1988-09-13 FI FI884192A patent/FI94837C/fi not_active IP Right Cessation
- 1988-09-13 NZ NZ226163A patent/NZ226163A/xx unknown
- 1988-09-14 AT AT0224988A patent/AT395819B/de not_active IP Right Cessation
- 1988-09-14 JP JP63231396A patent/JP3090666B2/ja not_active Expired - Lifetime
- 1988-09-14 KR KR1019880011874A patent/KR0131084B1/ko not_active IP Right Cessation
- 1988-09-14 IT IT8848349A patent/IT1224886B/it active
- 1988-09-14 MY MYPI88001027A patent/MY103769A/en unknown
- 1988-09-14 DK DK198805111A patent/DK175132B1/da not_active IP Right Cessation
- 1988-09-14 IL IL87746A patent/IL87746A/xx active Protection Beyond IP Right Term
- 1988-09-14 GR GR880100602A patent/GR1002243B/el not_active IP Right Cessation
- 1988-09-15 NL NL8802275A patent/NL195094C/nl not_active IP Right Cessation
- 1988-09-15 ES ES8802831A patent/ES2012118A6/es not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUT47552A (en) | Process for producing 10-dihydro-10-deoxo-11-aza-erythronolid a derivatives and pharmaceutical compositions containing them as active components | |
| HUT46710A (en) | Process for producing peptode derivatives and pharmaceutical compositions containing them as active components | |
| HUT49290A (en) | Process for producing retarde pharmaceutical compositions | |
| HUT47022A (en) | Process for production of medical compositions | |
| HUT54999A (en) | Process for producing imidazolyl-alkenic acids and pharmaceutical compositions containing them as active components | |
| HUT48267A (en) | Process for producing fluoro-citidin derivatives and pharmaceutical compositions containing them | |
| HUT47274A (en) | Process for producing terciary hydroxy-alkyl-xantines and pharmaceutical compositions containing them as active components | |
| HUT48247A (en) | Process for producing aza-bicyclo-octyl-ether derivatives and pharmaceutical compositions containing them as active components | |
| HUT45252A (en) | Process for producing imidazo-pyridine derivatives and pharmaceutical compositions containing them as active components | |
| HUT49494A (en) | Process for producing active component of pharmaceutical compositions | |
| HUT51279A (en) | Process for producing 2-phosphate-esters of ascorbinic acid and pharmaceutical compositions containing them as active components | |
| HUT37781A (en) | Process for producing 1-fluorphenyl-butyl-4-/2-pirimidinyl/-piperazine derivatives and pharmaceutical compositions containing them as active agents | |
| HUT48269A (en) | Process for producing pharmaceutically active nukleozide and pharmaceutical compositions containing them | |
| HUT47865A (en) | Process for producing pharmaceutical compositions containing somatostatin as active component | |
| HUT48902A (en) | Process for producing new ribofuranuronic acid derivatives and pharmaceutical compositions containing them | |
| HUT50121A (en) | Process for producing piperidinyl-derivatives and pharmaceutical compositions containing them | |
| HUT47079A (en) | Process for producing n-amino-butyl-n-phenyl-aryl-amide derivatives and pharmaceutical compositions containing them | |
| HUT50473A (en) | Process for producing imidazopyridazinones and pharmaceutical compositions comprising such compounds | |
| HUT46930A (en) | Process for producing aminoglycoside-steroides and pharmaceutical compositions containing them as active components | |
| HUT54671A (en) | Process for producing benzothiopirane derivatives and pharmaceutical compositions containing them as active component | |
| HUT48870A (en) | Process for producing aminoalkoxyphenyl derivatives and pharmaceutical compositions comprising same | |
| HUT48251A (en) | Process for producing new xantin derivatives and pharmaceutical compositions containing them as active components | |
| HUT53866A (en) | Process for producing new ammonium compounds and pharmaceutical compositions comprising such compounds | |
| HUT50112A (en) | Process for producing phenoxyalkyl-carboxylic acid derivatives and pharmaceutical compositions containing them as active component | |
| HUT47119A (en) | Process for producing 3-propenyl-cefem derivatives and pharmaceutical compositions comprising such compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HPC4 | Succession in title of patentee |
Owner name: NOVARTIS A.G., CH |